Article

A systems biology-based study to assess the effects of TNF-α ± apigenin in triple-negative breast cancer cell line

2024-01-12

Abstract excerpt

<h4>Background: </h4> Triple-negative breast cancer (TNBC) refers to the type of breast cancer with no estrogen, progesterone, and HER2 receptors. Various methods can be applied to treating patients with BC, among which the therapeutic-based ones without toxic side effects are extremely important. In this study, we computationally investigated the impact of apigenin on the TNBC cell line as traditional Chinese med...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: af833b5d-ca3f-5dfe-8bef-abdc7ae13dcb
DOI: 10.21203/rs.3.rs-3837360/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A systems biology-based study to assess the effects of TNF-α ± apigenin in triple-negative breast cancer cell lineDOI 10.21203/rs.3.rs-3837360/v1Read

A Network Pharmacology Study on the Molecular Mechanisms of FDY003 for Breast Cancer TreatmentSemantic proximity Read

The potential mechanism of pachymic acid in triple-negative breast cancer: a network pharmacology and vitro experimentsSemantic proximity Read

Cordycepin Combined with Doxorubicin Inhibits Triple-negative Breast Cancer by TNF Signaling PathwaysSemantic proximity Read

Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatmentSemantic proximity Read

Investigating the Inhibitory Aspects of Metformin/Curcumin Co-Treatment through Convergence of In-Silico and In-Vitro ApproachesSemantic proximity Read

Tracing the pathways and mechanisms involved in the anti-breast cancer activity of glycyrrhizin using bioinformatics tools and computational methodsSemantic proximity Read

Apigenin as an effective anticancer natural product: Spotlight on TRAIL, WNT/β‐catenin, JAK‐STAT pathways, and microRNAsSemantic proximity Read

Selected Ideal Natural Ligand Against TNBC by Inhibiting CDC20, Using Bioinformatics and Molecular BiologySemantic proximity Read

Molecular Docking Appraisal of Dysphania ambrosioides Phytochemicals as Potential Inhibitor of a Key Triple-negative Breast Cancer Driver GeneSemantic proximity Read

Molecular mechanisms of Rhizoma Dioscoreae in breast cancer treatment: a network pharmacology and experimental verificationSemantic proximity Read

A systems pharmacology approach to determine the mechanisms of action of pleiotropic natural products in breast cancer from transcriptome dataSemantic proximity Read

Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancerSemantic proximity Read